The articles in this collection have been identified by the Editor-in-Chief as a sampling of must-read MCT reviews published in 2017. We hope these articles provide you with an in-depth view on target identification, the development of cancer therapeutics, and the mechanism of drug resistance.
:: 2019 Archive :: 2018 Archive :: 2017 Archive
2017
- Path toward Precision Oncology: Review of Targeted Therapy Studies and Tools to Aid in Defining "Actionability" of a Molecular Lesion and Patient Management Support
Chae YK…Giles FJ. Molecular Cancer Therapeutics December 2017. - New B7 Family Checkpoints in Human Cancers
Ni L and Dong C. Molecular Cancer Therapeutics July 2017. - FLT3 Inhibitors in Acute Myeloid Leukemia: Current Status and Future Directions
Larrosa-Garcia M…Baer MR. Molecular Cancer Therapeutics June 2017. - The Slow Cycling Phenotype: A Growing Problem for Treatment Resistance in Melanoma
Ahn A…Eccles MR. Molecular Cancer Therapeutics June 2017. - The Role of CtBP1 in Oncogenic Processes and Its Potential as a Therapeutic Target
Blevins MA…Zhao R. Molecular Cancer Therapeutics June 2017. - Hey Factors at the Crossroad of Tumorigenesis and Clinical Therapeutic Modulation of Hey for Anticancer Treatment
Liu Z…Gong C. Molecular Cancer Therapeutics May 2017. - Nodal Signaling as a Developmental Therapeutics Target in Oncology
Kalyan A…Giles F. Molecular Cancer Therapeutics May 2017. - MET in Lung Cancer: Biomarker Selection Based on Scientific Rationale
Salgia R. Molecular Cancer Therapeutics April 2017. - Strategies to Overcome Bypass Mechanisms Mediating Clinical Resistance to EGFR Tyrosine Kinase Inhibition in Lung Cancer
Husain H…Kurzrock R. Molecular Cancer Therapeutics February 2017.
Molecular Cancer Therapeutics Editorial Office
American Association for Cancer Research | Publications Division
615 Chestnut Street | 17th Floor | Philadelphia, PA 19106-4404
Phone: (215) 440-9300 | Fax: (267) 765-1090 | E-mail: mct@aacr.org